D.A. Davidson & Co
MED icon

D.A. Davidson & Co’s Medifast MED Stock Holding History

D.A. Davidson & Co’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,268
Closed -$287K – 1433
2023
Q4 		$287K Sell
4,268
-1,036
-20% -$72.2K ﹤0.01% 1138
2023
Q3 		$397K Buy
5,304
+771
+17% +$68.4K ﹤0.01% 985
2023
Q2 		$418K Buy
4,533
+486
+12% +$43.3K ﹤0.01% 971
2023
Q1 		$420K Buy
4,047
+456
+13% +$50.5K ﹤0.01% 946
2022
Q4 		$414K Buy
3,591
+85
+2% +$9.9K ﹤0.01% 922
2022
Q3 		$380K Buy
3,506
+1,867
+114% +$268K 0.01% 911
2022
Q2 		$296K Buy
1,639
+18
+1% +$3.22K ﹤0.01% 1018
2022
Q1 		$277K Buy
1,621
+30
+2% +$5.66K ﹤0.01% 1102
2021
Q4 		$333K Buy
+1,591
New +$329K ﹤0.01% 1017

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

D.A. Davidson & Co's MED Position: Q1 2024 in Review

D.A. Davidson & Co sold out of Medifast (MED) in Q1 2024, closing a stake of 4,268 shares — an estimated $287K sold.

D.A. Davidson & Co first reported a position in MED in Q4 2021 and held it in 9 quarters. The position peaked at $420K in Q1 2023. 186 funds tracked by Wall St. Rank hold MED as of Q1 2024.

  • D.A. Davidson & Co reported no remaining Medifast position as of Q1 2024 after selling out during the quarter.
  • D.A. Davidson & Co sold 4,268 Medifast shares in Q1 2024, an estimated $287K.
  • D.A. Davidson & Co first reported a position in Medifast in Q4 2021 and held it in 9 quarters.
  • D.A. Davidson & Co's Medifast position peaked at $420K in Q1 2023.
  • 186 funds tracked by Wall St. Rank held Medifast as of Q1 2024.

Based on D.A. Davidson & Co's 13F filing for Q1 2024, filed 13 May 2024.